Table 2 Demographics of subjects included in the study
Study | Total Subjects (female %) | Age in Years Mean (std) | Duration of Disease in Years Mean (std) | H&Y Median | MoCA Mean (std) | MDS-UPDRS3 for PD (std) | Clinical Diagnostic Criteria | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
PD | HC | PD | HC | PD | PD | HC | PD | HC | |||
PPMI | 222 (34.6%) | 64 (36.3%) | 62.4 (9.4) | 60.2 (10.8) | 0.55 (0.56) | 2 | - - | 27.37 (2.21) | 28.22 (1.14) | 20.96 (9.32) | MDS |
COMPASS-ND | 65 (32.3%) | - | 69.1 (7.3) | - | - | 2 | - | 24.23 (4.83) | - | 9.07 (5.33) | MDS |
PD-MCI Calgary | 108 (34.2%) | 42 (52.3%) | 70.5 (6.2) | 69.5 (6.7) | 5.94 (4.51) | - | - | 25.57 (2.94) | 27.35 (1.94) | 19.50 (12.54) | MDS |
C-Big | 82 (42.6%) | 11 (81.8%) | 64.1 (8.6) | 64.2 (12.8) | - | - | - | - | - | 38.88 (14.18) | MDS |
Hamburg | 49 (28.5%) | 39 (37.5%) | 65.4 (8.2) | 62.5 (11.6) | 12.82 (6.94) | 2 | - | - | - | 27.10 (10.40) | UKBB |
UK Biobank | 42 (45.2%) | 192 (40.1%) | 69.4 (5.9) | (66.3) (7.6) | 7.46 (6.62) | - | - | - | - | - | UKBB |
PD-MCI Montreal | 43 (39.5%) | 20 (50.0%) | 62.1 (5.7) | 62.4 (6.2) | 4.98 (3.80) | - | - | 27.23 (1.99) | 27.80 (1.93) | 29.69 (8.20) | UKBB |
ADNI | - | 285 (65.6%) | - | 67.7 (4.3) | - | - | - | - | - | - | - |
Total | 611 (37.6%) | 653 (37.5%) | 65.5 (8.7) | 66.1 (7.6) | - | - | - | - | - | - | MDS and UKBB |
